Clinical Trials Directory

Trials / Completed

CompletedNCT06860308

The Effect of Norepinephrine on the Development of Pressure Injury

The Determination of the Effect of Norepinephrine Infusion on the Development of Pressure Injury Among Critically Ill Patients

Status
Completed
Phase
Study type
Observational
Enrollment
289 (actual)
Sponsor
Koç University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Norepinephrine mainly increases mean arterial pressure among intensive care patients. It may be an essential risk factor in developing pressure injuries. However, there are still conflicting findings in the literature. This study aimed to examine the effect of norepinephrine infusion on the development of pressure injuries among patients in adult intensive care. This retrospective and correlational study was conducted between March 2021- May 2022. The electronic patient data were obtained from 289 adult patients (Case group n=149; control group n=149) treated with and without norepinephrine in the intensive care unit, respectively. The demographic and clinical characteristics were evaluated using descriptive statistical methods (number, percentage, mean, standard deviation). A logistic regression model was established to estimate the dependent variable (development of pressure injury) with the independent variables.

Conditions

Timeline

Start date
2024-12-01
Primary completion
2025-01-31
Completion
2025-02-20
First posted
2025-03-06
Last updated
2025-03-06

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06860308. Inclusion in this directory is not an endorsement.